Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice

scientific article published in April 1999

Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID10191288

P2093author name stringGlick JM
Rader DJ
de Beer FC
Tietge UJ
Webb NR
Hosoai H
Purdom MS
P433issue4
P304page(s)648-653
P577publication date1999-04-01
P1433published inJournal of Lipid ResearchQ6295449
P1476titleExpression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice
P478volume40

Reverse relations

cites work (P2860)
Q33551127Apolipoprotein A-I and serum amyloid A plasma levels are biomarkers of acute painful episodes in patients with sickle cell disease
Q55089258Apolipoprotein A-II induces acute-phase response associated AA amyloidosis in mice through conformational changes of plasma lipoprotein structure.
Q92598907Association of acute Babesia canis infection and serum lipid, lipoprotein, and apoprotein concentrations in dogs
Q46969698Changes in plasma LDL and HDL composition in patients undergoing cardiac surgery
Q34764150Characterization of the oligomerization and aggregation of human Serum Amyloid A
Q36771716Deficiency of Endogenous Acute-Phase Serum Amyloid A Protects apoE-/- Mice From Angiotensin II-Induced Abdominal Aortic Aneurysm Formation
Q33911023Establishment of a transgenic mouse model specifically expressing human serum amyloid A in adipose tissue
Q50047580Evaluation of Monocyte to High-Density Lipoprotein Cholesterol Ratio in the Presence and Severity of Metabolic Syndrome.
Q34187954Impact of serum amyloid A on high density lipoprotein composition and levels
Q36980202Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study
Q35886286Inflammatory remodeling of the HDL proteome impairs cholesterol efflux capacity
Q39293001Lipid testing in infectious diseases: possible role in diagnosis and prognosis
Q33741235Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response but not group IIA secretory phospholipase A(2)
Q36681188Neutrophil effector responses are suppressed by secretory phospholipase A2 modified HDL.
Q44068930Plasma Atherogenic Index is an Independent Indicator of Subclinical Atherosclerosis in Systemic Lupus Erythematosus.
Q35087226Serum amyloid A facilitates the binding of high-density lipoprotein from mice injected with lipopolysaccharide to vascular proteoglycans
Q28298733Serum amyloid A induces G-CSF expression and neutrophilia via Toll-like receptor 2
Q37061136Serum amyloid A, but not C-reactive protein, stimulates vascular proteoglycan synthesis in a pro-atherogenic manner
Q38761950Serum amyloid A1: Structure, function and gene polymorphism
Q35886290Thermal transitions in serum amyloid A in solution and on the lipid: implications for structure and stability of acute-phase HDL.
Q33742998Type 2 Diabetes in Young Females Results in Increased Serum Amyloid A and Changes to Features of High Density Lipoproteins in Both HDL2 and HDL3.

Search more.